Lignocaine/ Adrenaline
Indications
Registered South African indications:
- Local anaesthetic
- Dental extractions or operations
Cautions
Contraindications
- Hypersensitivity to local anaesthetics of the amide type (e.g. lidocaine hydrochloride)
- Patients with thyrotoxicosis
- Cardiac disease, particularly those with arrhythmia or hypertension
- Narrow-angle glaucoma
- Patients with myasthenia gravis
- Coadministration with tricyclic antidepressants
Cautions
- Breastfeeding
- Hepatic impairment
- Intravenous administration
- Epilepsy
- Myasthenia gravis
Adult dosage
Forms avail. in SA and in this monograph: inj
Local anaesthetic
Dental extractions
- Local infiltration: Dosage dependant on nature, magnitude and duration of procedure involved; Max: 7mg/kg
Paediatric dosage
See adult dosage
Special populations
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Porphyria Information
Drugs in Sport
- Permitted - No warnings
Adverse reactions
Central Nervous System Disorders
- Seizures
Cardiovascular Disorders
- Hypotension
- Arrhythmias
- Cardiovascular collapse
Respiratory Disorders
- Respiratory collapse
Gastrointestinal Disorders
- Nausea and vomiting
Musculoskeletal Disorders
- Muscle twitching
Interactions
- Tricyclic antidepressants
- Monoamine oxidase inhibitors
- Alpha blockers
- Beta blockers
Monitoring
None routine
Mechanism of action
Lignocaine stabilizes the neuronal membrane by inhibiting the ionic fluxes required for the initiation and conduction of impulses thereby effecting local anesthetic action. Lignocaine alters signal conduction in neurons by blocking the fast voltage gated sodium (Na+) channels in the neuronal cell membrane that are responsible for signal propagation. With sufficient blockage the membrane of the postsynaptic neuron will not depolarize and will thus fail to transmit an action potential. This creates the anaesthetic effect by not merely preventing pain signals from propagating to the brain but by aborting their birth in the first place.
Dosage forms
- Injection
Formulation
COMBINATION PREPARATIONS
Lignocaine/ Adrenaline
Injection (per ml) 20mg/12.5μg
- Xylotox E80-A (Adcock Ingram) originator
References
1. PI: Xylotox E80-A Solution for Injection, Adcock Ingram Ltd:Date of registration: 2 Jul 1982 [https://drive.google.com/drive/u/0/folders/1prMse03xQI-j_2v1xk8Ko__o4X0jFLA0] 2. PI - XYLOTOX E80-A, Adcock Ingram Limited - DATE OF PUBLICATION OF THIS PACKAGE INSERT: 11 October 2013 Downloaded online 30 Sept 2024 [https://www.adcockingramrx.co.za/hcphub/handle-file?fileid=338]
Brands & products
3 products · cached snapshot- Xylotox E80-A
INJInjection· 3 products
from R274.32| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Xylestesin-A | 20 mg/ml;µg/ml | 50 | 3M South Africa (Pty) Ltd | R274.32 |
| Lignospan 2% | 20 mg/ml;µg/ml | 1.8 | Henry Schein Dental Warehouse (Pty) Ltd | R511.27 |
| Xylotox E80-A | 20 mg/ml;µg/ml | 1.8 | Adcock Ingram Limited | R1026.68 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.